• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名克罗恩病患者发生药物性反向银屑病

Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn's Disease.

作者信息

Darwin Evan, Deshpande Amar, Lev-Tov Hadar

机构信息

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL.

Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.

出版信息

ACG Case Rep J. 2018 Jun 20;5:e47. doi: 10.14309/crj.2018.47. eCollection 2018.

DOI:10.14309/crj.2018.47
PMID:29951562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6013682/
Abstract

Crohn's disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported case of a flare of drug-induced psoriasis with ustekinumab, and it is the first reported case with an inverse presentation; however, the clinical picture is confounded by concomitant use of hydroxychloroquine. Inverse psoriasis is a rare variant of drug-induced psoriasis of which physicians must be cognizant while treating patients with Crohn's disease.

摘要

克罗恩病难以控制,通常需要多种药物治疗。虽然这些药物能极大地改善生活质量,但医生必须监测不良事件。我们报告一例在用优特克单抗治疗15个月后出现反向性银屑病发作的病例。这是第三例报道的优特克单抗诱发银屑病发作的病例,也是首例报道的反向性表现病例;然而,临床情况因同时使用羟氯喹而变得复杂。反向性银屑病是药物性银屑病的一种罕见变体,医生在治疗克罗恩病患者时必须对此有所认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7e/6013682/d5e7d049214f/CG-CGCR180038F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7e/6013682/d5e7d049214f/CG-CGCR180038F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7e/6013682/d5e7d049214f/CG-CGCR180038F001.jpg

相似文献

1
Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn's Disease.一名克罗恩病患者发生药物性反向银屑病
ACG Case Rep J. 2018 Jun 20;5:e47. doi: 10.14309/crj.2018.47. eCollection 2018.
2
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn's disease.优特克单抗治疗英夫利昔单抗诱导的与克罗恩病相关的银屑病和关节炎的疗效。
Biologics. 2018 Jul 19;12:69-73. doi: 10.2147/BTT.S169326. eCollection 2018.
3
Ustekinumab as a Treatment for Ixekizumab-Associated New-Onset Crohn's Disease in a Patient with Psoriasis.乌司奴单抗治疗一名银屑病患者中与司库奇尤单抗相关的新发克罗恩病
ACG Case Rep J. 2024 Jan 31;11(2):e01266. doi: 10.14309/crj.0000000000001266. eCollection 2024 Feb.
4
Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathy.英夫利昔单抗治疗克罗恩病相关性脊柱关节炎诱导的脓疱性银屑病:一种矛盾现象。
Rheumatol Int. 2018 Jul;38(7):1297-1299. doi: 10.1007/s00296-018-4034-0. Epub 2018 Apr 28.
5
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].[优特克单抗治疗克罗恩病合并抗TNF-α诱导的银屑病1例]
Gastroenterol Hepatol. 2011 Oct;34(8):546-50. doi: 10.1016/j.gastrohep.2011.04.003. Epub 2011 Jun 12.
6
7
Efficiency of Ustekinumab in Crohn's Disease with Severe Psoriasiform Rash Induced by Biotherapies in an Adolescent.司库奇尤单抗治疗一名青少年因生物疗法诱发严重银屑病样皮疹的克罗恩病的疗效
Pediatr Dermatol. 2017 Jul;34(4):e214-e215. doi: 10.1111/pde.13138. Epub 2017 Apr 23.
8
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.英夫利昔单抗治疗伴有银屑病或银屑病关节炎的炎症性肠病患者的真实疗效:IG-IBD 研究。
Dig Liver Dis. 2019 Jul;51(7):972-977. doi: 10.1016/j.dld.2019.03.007. Epub 2019 Apr 13.
9
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.在使用英夫利昔单抗治疗克罗恩病期间出现银屑病头皮伴脱发,且两病均对乌司奴单抗快速起效。
Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2831-6.
10
Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.乌司奴单抗治疗 TNF 拮抗剂诱导的银屑病关节炎患者银屑病恶化:病例报告及文献复习
Dermatology. 2012;225(1):14-7. doi: 10.1159/000339864. Epub 2012 Aug 10.

引用本文的文献

1
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies.银屑病与炎症性肠病:是合并存在的免疫介导性炎症性疾病还是矛盾的治疗效果?关于抗IL-12/23和抗IL-23抗体的综述
Therap Adv Gastroenterol. 2024 Nov 21;17:17562848241299564. doi: 10.1177/17562848241299564. eCollection 2024.
2
Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report.乌司奴单抗诱导的矛盾性银屑病:全面综述及病例报告。
Medicina (Kaunas). 2024 Jan 6;60(1):106. doi: 10.3390/medicina60010106.
3
Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.

本文引用的文献

1
Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.类风湿关节炎、幼年特发性关节炎和脊柱关节炎的皮肤表现。
Clin Rev Allergy Immunol. 2017 Dec;53(3):371-393. doi: 10.1007/s12016-017-8632-5.
2
Psoriasis Induced by Anti-Tumor Necrosis Factor Alpha Agents: A Comprehensive Review of the Literature.抗肿瘤坏死因子α制剂诱发的银屑病:文献综述
Acta Dermatovenerol Croat. 2016 Aug;24(3):169-74.
3
Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.接受乌司奴单抗治疗的银屑病患者出现的反常性银屑病关节炎。
羟氯喹对银屑病的作用:系统评价及对 COVID-19 治疗的警示。
J Am Acad Dermatol. 2020 Aug;83(2):579-586. doi: 10.1016/j.jaad.2020.05.074. Epub 2020 May 19.
4
Hydroxychloroquine-induced inverse psoriasis.羟氯喹诱发的反向银屑病。
BMJ Case Rep. 2019 Feb 28;12(2):e224619. doi: 10.1136/bcr-2018-224619.
Rheumatology (Oxford). 2015 Nov;54(11):2114-6. doi: 10.1093/rheumatology/kev263. Epub 2015 Aug 4.
4
Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?反向性银屑病:是一种独立的疾病还是寻常型银屑病的一种变异型?
Clin Dermatol. 2015 Jul-Aug;33(4):456-61. doi: 10.1016/j.clindermatol.2015.04.007. Epub 2015 Apr 8.
5
Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy.由优特克单抗引发的脓疱型银屑病矛盾性皮疹,对阿达木单抗治疗有反应。
Clin Exp Dermatol. 2014 Aug;39(6):751-2. doi: 10.1111/ced.12392. Epub 2014 Jul 1.
6
Psoriasis induced by thalidomide in a patient with multiple myeloma.沙利度胺诱发的多发性骨髓瘤患者银屑病。
BMJ Case Rep. 2014 Jun 27;2014:bcr2014204469. doi: 10.1136/bcr-2014-204469.
7
Synthetic antimalarial drugs and the triggering of psoriasis - do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria?合成抗疟药与银屑病的诱发——对于有疟疾风险的银屑病患者的管理,我们是否需要针对特定疾病的指南?
Int J Dermatol. 2014 Mar;53(3):327-30. doi: 10.1111/ijd.12231. Epub 2013 Dec 10.
8
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.抗 TNF 药物诱导炎症性肠病患者发生银屑病:21 例报告。
J Crohns Colitis. 2012 Jun;6(5):518-23. doi: 10.1016/j.crohns.2011.10.007. Epub 2011 Nov 13.
9
Flare of pustular psoriasis after initiating ustekinumab therapy.乌司奴单抗治疗后脓疱型银屑病发作。
J Dermatolog Treat. 2012 Jun;23(3):212-4. doi: 10.3109/09546634.2010.534430. Epub 2011 Jan 22.
10
Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management.皮肤药疹病理学和发病机制认识的进展:对治疗的启示
Am J Clin Dermatol. 2003;4(6):407-28. doi: 10.2165/00128071-200304060-00005.